SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance. Liu Z, Liu J, Ebrahimi B, Pratap UP, et al. Breast Cancer Res 2022;24:26.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Z, Liu J, Ebrahimi B, Pratap UP, et al. SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance. Breast Cancer Res 2022;24:26.
PMID: 35395812